Peri-transplant extracorporeal photopheresis to mitigate GVHD- a pilot clinical trial

Bone Marrow Transplant. 2021 Apr;56(4):980-982. doi: 10.1038/s41409-020-01142-4. Epub 2020 Nov 20.

Haitham Abdelhakim^{1

2}, Anthony Accurso³, Dean Merkel¹, Shaun Dejarnette¹, Omar Aljitawi⁴, Thomas Yankee⁵, Jianghua He⁶, Siddhartha Ganguly^{1

2}, Joseph McGuirk^{1

2}, Sunil Abhyankar^{7

8}

¹ Division of Hematological Malignancies and Cellular Therapy, University of Kansas Medical Center, Kansas City, KS, USA.
² University of Kansas Cancer Center, Kansas City, KS, USA.
³ Dreiling/Schmidt Cancer Institute, University of Kansas Health System, Hays, KS, USA.
⁴ Division of Hematology and Bone Marrow Transplantation, University of Rochester Medical Center, Rochester, NY, USA.
⁵ Department of Microbiology, Molecular Genetics & Immunology, University of Kansas School of Medicine, Kansas City, KS, USA.
⁶ Department of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
⁷ Division of Hematological Malignancies and Cellular Therapy, University of Kansas Medical Center, Kansas City, KS, USA. [email protected].
⁸ University of Kansas Cancer Center, Kansas City, KS, USA. [email protected].

No abstract available

Publication types